Visit COVID-19 resources

[Skip to Content]

Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma – (Eye Journal AOP)

1 April 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login